Eterna Health and Dr Adeel Khan Pioneer First Regenerative Treatment Using Small Pluripotent Stem Cells (SPSCs)

Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement

Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis

Sanofi's efdoralprin alfa shows superior results in phase 2 study for AATD

PureTech highlights Phase 2b data supporting deupirfenidone's safety and efficacy in older IPF patients

FDA accepts Xspray Pharma's NDA for XS003 with PDUFA date set for June 2026

Citius Oncology and McKesson sign US distribution agreement for LYMPHIR

Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio

Genentech's Gazyva (obinutuzumab) receives US FDA approval to treat adults with lupus nephritis

AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps

Antengene reveals ATG-022 clinical data at ESMO 2025

WeightWatchers launches RxFlexFund to expand affordable GLP-1 access for employers and employees

Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025

Merck reports positive Phase 3 data for investigational two-drug HIV regimen doravirine/islatravir

60 Degrees reports first patient has tested negative for babesiosis in tafenoquine study